Flagship Biosciences Is Honored with a Best Practices Award

We are honored to announce that Flagship Biosciences has earned a Frost & Sullivan 2023 North American Customer Value Leadership Award in the AI-enabled digital pathology solutions market.

Following from detailed evaluation of best practices criteria, the award recognizes a company that offers products or services customers find superior for overall price, performance, and quality.

Flagship is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We provide end-to-end, AI-powered, digital pathology solutions for clinical trials in validated settings. Our customers have access to innovative technology customized to meet their drug development needs and regulatory requirements.

Flagship prides itself in providing exemplary customer service and in partnering with companies to offer expert scientific consultation for every client. Our customers know us for our flexibility, deep scientific understanding, and purposeful AI-powered solutions instead of cookie-cutter services.

Our clients are at the heart of what we do every day, and we are honored to have received this prestigious award.

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Flagship Biosciences hires Tom Turi, Ph.D. as CSO

Accomplished industry executive strengthens company’s position as a leader in spatial biology and biomarker analytics.BROOMFIELD, CO - September 27, 2022 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring...